Literature DB >> 32187354

Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemia.

Katherine Tarlock1,2, Todd Alonzo3,4, Yi-Cheng Wang4, Robert B Gerbing4, Rhonda E Ries2, Tiffany Hylkema2, Jenny L Smith2, Julia E Maxson5, Soheil Meshinchi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32187354      PMCID： PMC7193184          DOI： 10.1182/blood.2019004179

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  24 in total

1.  Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent CSF3R mutations in chronic neutrophilic leukemia.

Authors:  Arief S Gunawan; Donal P McLornan; Bridget Wilkins; Katherine Waghorn; Yvette Hoade; Nicholas C P Cross; Claire N Harrison
Journal:  Haematologica       Date:  2017-03-16       Impact factor: 9.941

2.  CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML.

Authors:  Julia E Maxson; Rhonda E Ries; Yi-Cheng Wang; Robert B Gerbing; E Anders Kolb; Sarah L Thompson; Jaime M Guidry Auvil; Marco A Marra; Yussanne Ma; Zusheng Zong; Andrew J Mungall; Richard Moore; William Long; Patee Gesuwan; Tanja M Davidsen; Leandro C Hermida; Seamus B Hughes; Jason E Farrar; Jerald P Radich; Malcolm A Smith; Daniela S Gerhard; Alan S Gamis; Todd A Alonzo; Soheil Meshinchi
Journal:  Blood       Date:  2016-05-03       Impact factor: 22.113

3.  CSF3R and CALR mutations in paediatric myeloid disorders and the association of CSF3R mutations with translocations, including t(8; 21).

Authors:  Hitoshi Sano; Kentaro Ohki; Myoung-Ja Park; Norio Shiba; Yusuke Hara; Manabu Sotomatsu; Daisuke Tomizawa; Takashi Taga; Nobutaka Kiyokawa; Akio Tawa; Keizo Horibe; Souichi Adachi; Yasuhide Hayashi
Journal:  Br J Haematol       Date:  2015-04-09       Impact factor: 6.998

4.  The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.

Authors:  Hamid Bolouri; Jason E Farrar; Timothy Triche; Rhonda E Ries; Emilia L Lim; Todd A Alonzo; Yussanne Ma; Richard Moore; Andrew J Mungall; Marco A Marra; Jinghui Zhang; Xiaotu Ma; Yu Liu; Yanling Liu; Jaime M Guidry Auvil; Tanja M Davidsen; Patee Gesuwan; Leandro C Hermida; Bodour Salhia; Stephen Capone; Giridharan Ramsingh; Christian Michel Zwaan; Sanne Noort; Stephen R Piccolo; E Anders Kolb; Alan S Gamis; Malcolm A Smith; Daniela S Gerhard; Soheil Meshinchi
Journal:  Nat Med       Date:  2017-12-11       Impact factor: 53.440

Review 5.  Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies.

Authors:  Pankaj Dwivedi; Kenneth D Greis
Journal:  Exp Hematol       Date:  2016-10-24       Impact factor: 3.084

6.  G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses.

Authors:  Quan-Sheng Zhu; Lisa J Robinson; Vera Roginskaya; Seth J Corey
Journal:  Blood       Date:  2003-12-04       Impact factor: 22.113

7.  CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.

Authors:  A Pardanani; T L Lasho; R R Laborde; M Elliott; C A Hanson; R A Knudson; R P Ketterling; J E Maxson; J W Tyner; A Tefferi
Journal:  Leukemia       Date:  2013-04-22       Impact factor: 11.528

8.  Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation.

Authors:  S E Nicholson; A C Oates; A G Harpur; A Ziemiecki; A F Wilks; J E Layton
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

9.  Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance.

Authors:  Long Su; YeHui Tan; Hai Lin; XiaoLiang Liu; Li Yu; YanPing Yang; ShanShan Liu; Ou Bai; Yan Yang; FengYan Jin; JingNan Sun; ChunShui Liu; QiuJu Liu; SuJun Gao; Wei Li
Journal:  Oncotarget       Date:  2018-01-03

10.  Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.

Authors:  Theodore P Braun; Mariam Okhovat; Cody Coblentz; Sarah A Carratt; Amy Foley; Zachary Schonrock; Brittany M Curtiss; Kimberly Nevonen; Brett Davis; Brianna Garcia; Dorian LaTocha; Benjamin R Weeder; Michal R Grzadkowski; Joey C Estabrook; Hannah G Manning; Kevin Watanabe-Smith; Sophia Jeng; Jenny L Smith; Amanda R Leonti; Rhonda E Ries; Shannon McWeeney; Cristina Di Genua; Roy Drissen; Claus Nerlov; Soheil Meshinchi; Lucia Carbone; Brian J Druker; Julia E Maxson
Journal:  Nat Commun       Date:  2019-11-29       Impact factor: 17.694
View more
  4 in total

Review 1.  Zebrafish models of acute leukemias: Current models and future directions.

Authors:  Brandon Molina; Jasmine Chavez; Stephanie Grainger
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2020-12-19       Impact factor: 5.814

2.  CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group.

Authors:  Katherine Tarlock; Adam J Lamble; Yi-Cheng Wang; Robert B Gerbing; Rhonda E Ries; Michael R Loken; Lisa Eidenschink Brodersen; Laura Pardo; Amanda Leonti; Jenny L Smith; Tiffany A Hylkema; William G Woods; Todd M Cooper; E Anders Kolb; Alan S Gamis; Richard Aplenc; Todd A Alonzo; Soheil Meshinchi
Journal:  Blood       Date:  2021-09-30       Impact factor: 25.476

3.  Mutational Landscape of CEBPA in Mexican Pediatric Acute Myeloid Leukemia Patients: Prognostic Implications.

Authors:  Carolina Molina Garay; Karol Carrillo Sánchez; Luis Leonardo Flores Lagunes; Marco Jiménez Olivares; Anallely Muñoz Rivas; Beatríz Eugenia Villegas Torres; Hilario Flores Aguilar; Juan Carlos Núñez Enríquez; Elva Jiménez Hernández; Vilma Carolina Bekker Méndez; José Refugio Torres Nava; Janet Flores Lujano; Jorge Alfonso Martín Trejo; Minerva Mata Rocha; Aurora Medina Sansón; Laura Eugenia Espinoza Hernández; José Gabriel Peñaloza Gonzalez; Rosa Martha Espinosa Elizondo; Luz Victoria Flores Villegas; Raquel Amador Sanchez; María Luisa Pérez Saldívar; Omar Alejandro Sepúlveda Robles; Haydeé Rosas Vargas; Silvia Jiménez Morales; Patricia Galindo Delgado; Juan Manuel Mejía Aranguré; Carmen Alaez Verson
Journal:  Front Pediatr       Date:  2022-07-11       Impact factor: 3.569

4.  Identification of CSF3R Mutations in B-Lineage Acute Lymphoblastic Leukemia Using Comprehensive Cancer Panel and Next-Generation Sequencing.

Authors:  Mamoon Rashid; Abdulrahman Alasiri; Mohammad A Al Balwi; Aziza Alkhaldi; Ahmed Alsuhaibani; Abdulrahman Alsultan; Talal Alharbi; Lamya Alomair; Bader Almuzzaini
Journal:  Genes (Basel)       Date:  2021-08-27       Impact factor: 4.096
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.